Reasons for new paediatric HIV infections: findings from a cohort of HIV infected children screened at Harare Family Care Clinical Research Site.

International Workshop on HIV & Pediatrics 2019

Disclosure status among newly diagnosed HIV-infected adolescents aged 10-14 years: Findings from a facility-based study in Ethiopia

International Workshop on HIV & Pediatrics 2019

APOBEC editing in HIV DNA proviral vif and pol long-reads issued from virologically-suppressed patients included in the ANRS LAMIDOL trial

European Meeting on HIV & Hepatitis 2021

“Bring back mother-baby pair” campaign Initiative to improve retention in care: Experience from the Uganda program for Prevention of Mother to child transmission of HIV

INTEREST 2020

O_12: Examining the Basis of Drug-Drug Interaction Labeling Recommendations for Antiviral Approvals from 1998 to 2015- Tyler Shugg, PharmD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

PrEP: Updates on Programs from Across the Region - Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD

2nd African Workshop on Women & HIV 2025

Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience – Part 2 | Fiona Marra, MPharm, MSc

Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022

Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience - Part 1 | Catia Marzolini, PharmD, PhD

Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022

Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general population

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021